Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mittelman

Showing results (61-70 of 354) with videos related to

Pageof 36
Sort By:
Leukemia & Lymphoma|February 1, 1994
Treatment of gancyclovir resistant cytomegalovirus with foscarnet: a report of two cases occurring after bone marrow transplantationE Razis, P Cook, A Mittelman, et al.
Journal of the National Cancer Institute|March 1, 1974
Differential susceptibility of four mouse strains to induction of multiple large-bowel neoplasms by 1,2-dimethylhydrazineJ T Evans, T S Hauschka, A Mittelman
Journal of Surgical Oncology|January 1, 1972
Obstructive jaundice in macroglobulinemiaE G Elias, E D Holyoke, A Mittelman
Urology|June 1, 1984
Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by roswell park memorial instituteG P Murphy, N H Slack, A Mittelman
Hybridoma|April 1, 1995
Antiantiidiotypic response and clinical course of the disease in patients with malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23A Mittelman, X Wang, K Matsumoto, et al.
Analytical Biochemistry|October 1, 1976
Separation of naturally occurring 3',5'-cyclic ribonucleotides using high pressure liquid chromatographyS P Dutta, A Mittelman, G B Chhed'a
The Mount Sinai Journal of Medicine, New York|May 1, 1992
Humoral antimelanoma immunity: induction by mouse antiidiotypic mAb, MK2-23 and association with survival of patients with advanced melanomaA Mittelman, C Puccio, H Chun, et al.
Surgery|October 1, 1972
Exploratory laparotomy for staging of lymphomasE G Elias, J S Park, A Mittelman
Biochemical Medicine|April 1, 1980
Metabolism of 1,N6-ethenoadenosineS P Dutta, A Mittelman, G B Chheda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Phase II trial of Serratia marcescens extract in recurrent malignant astrocytomaK A Jaeckle, A Mittelman, F H Hill
Pageof 36

Showing results (61-70 of 354) with videos related to

Sort By:
Pageof 36
Leukemia & Lymphoma|February 1, 1994
Treatment of gancyclovir resistant cytomegalovirus with foscarnet: a report of two cases occurring after bone marrow transplantationE Razis, P Cook, A Mittelman, et al.
Journal of the National Cancer Institute|March 1, 1974
Differential susceptibility of four mouse strains to induction of multiple large-bowel neoplasms by 1,2-dimethylhydrazineJ T Evans, T S Hauschka, A Mittelman
Journal of Surgical Oncology|January 1, 1972
Obstructive jaundice in macroglobulinemiaE G Elias, E D Holyoke, A Mittelman
Urology|June 1, 1984
Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by roswell park memorial instituteG P Murphy, N H Slack, A Mittelman
Hybridoma|April 1, 1995
Antiantiidiotypic response and clinical course of the disease in patients with malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23A Mittelman, X Wang, K Matsumoto, et al.
Analytical Biochemistry|October 1, 1976
Separation of naturally occurring 3',5'-cyclic ribonucleotides using high pressure liquid chromatographyS P Dutta, A Mittelman, G B Chhed'a
The Mount Sinai Journal of Medicine, New York|May 1, 1992
Humoral antimelanoma immunity: induction by mouse antiidiotypic mAb, MK2-23 and association with survival of patients with advanced melanomaA Mittelman, C Puccio, H Chun, et al.
Surgery|October 1, 1972
Exploratory laparotomy for staging of lymphomasE G Elias, J S Park, A Mittelman
Biochemical Medicine|April 1, 1980
Metabolism of 1,N6-ethenoadenosineS P Dutta, A Mittelman, G B Chheda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Phase II trial of Serratia marcescens extract in recurrent malignant astrocytomaK A Jaeckle, A Mittelman, F H Hill
Pageof 36